Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Parasitol ; 43(14): 1133-9, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24162076

ABSTRACT

We have shown that Fasciola hepatica expresses at least six ß-tubulins in the adult stage of its life cycle, designated F.hep-ß-tub1-6 (Ryan et al., 2008). Here we show that different complements of tubulin isotypes are expressed in different tissues and at different life cycle stages; this information may inform the search for novel anthelmintics. The predominant (as judged by quantitative PCR) isotype transcribed at the adult stage was F.hep-ß-tub1 and immunolocalisation studies revealed that this isotype occurred mainly in mature spermatozoa and vitelline follicles. Quantitative PCR indicated that changes occurred in the transcription levels of ß-tubulin isotypes at certain life cycle stages and may be of importance in the efficacy of benzimidazole-based anthelmintic drugs, but there were no significant differences between the triclabendazole-susceptible Leon isolate and the triclabendazole-resistant Oberon isolate in the transcription levels of each of the isotypes. When three well-characterised isolates with differing susceptibilities to triclabendazole were compared, only one amino acid change resulting from a homozygous coding sequence difference (Gly269Ser) in isotype 4 was observed. However, this change was not predicted to alter the overall structure of the protein. In conclusion, these findings indicate that there is tissue-specific expression of tubulin isotypes in the liver fluke but the development of resistance to triclabendazole is not associated with changes in its presumed target molecule.


Subject(s)
Fasciola hepatica/growth & development , Fasciola hepatica/genetics , Gene Expression Regulation, Developmental , Life Cycle Stages , Tubulin/biosynthesis , Tubulin/genetics , Animals , Anthelmintics/pharmacology , Benzimidazoles/pharmacology , Drug Resistance , Fasciola hepatica/drug effects , Gene Expression Profiling , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , Real-Time Polymerase Chain Reaction , Transcription, Genetic , Triclabendazole
2.
Vet Parasitol ; 191(1-2): 161-4, 2013 Jan 16.
Article in English | MEDLINE | ID: mdl-22925823

ABSTRACT

We have determined the mitochondrial genotype of liver fluke present in Bison (Bison bonasus) from the herd maintained in the Bialowieza National Park in order to determine the origin of the infection. Our results demonstrated that the infrapopulations present in the bison were genetically diverse and were likely to have been derived from the population present in local cattle. From a consideration of the genetic structure of the liver fluke infrapopulations we conclude that the provision of hay at feeding stations may be implicated in the transmission of this parasite to the bison. This information may be of relevance to the successful management of the herd.


Subject(s)
Bison/parasitology , Cattle Diseases/parasitology , DNA, Mitochondrial/genetics , Fasciola hepatica/classification , Fasciola hepatica/genetics , Fascioliasis/veterinary , Animals , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/transmission , Fascioliasis/epidemiology , Fascioliasis/parasitology , Fascioliasis/transmission , Haplotypes , Prevalence , Species Specificity , Trees
3.
Trans R Soc Trop Med Hyg ; 101(12): 1219-22, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17905370

ABSTRACT

Triclabendazole is the drug of choice against Fasciola hepatica infections in humans and animals. However, parasite resistance against triclabendazole is spreading in the veterinary field, and there are no drugs of comparable activity currently available for the treatment and control of fascioliasis. We investigated the efficacy of single oral doses of artemether and OZ78 against adult triclabendazole-resistant F. hepatica harboured in rats, and compared the results with triclabendazole administered at two different doses. Single oral doses of 100 mg/kg OZ78 and 200 mg/kg artemether resulted in worm burden reductions of 100%. Whereas a single 10 mg/kg dose of triclabendazole achieved a worm burden reduction of only 4.0%, a five-fold higher dose yielded a significant worm burden reduction of 60.9%. However, the lower dose of triclabendazole administered to rats harbouring a triclabendazole-sensitive F. hepatica isolate resulted in a worm burden reduction of 95.3%. Our findings confirm that artemether and OZ78 possess good fasciocidal properties, even against a triclabendazole-resistant F. hepatica isolate, and hence these drugs might become useful in areas where triclabendazole resistance is common.


Subject(s)
Adamantane/analogs & derivatives , Antiplatyhelmintic Agents/therapeutic use , Artemisinins/therapeutic use , Fasciola hepatica/drug effects , Fascioliasis/drug therapy , Adamantane/therapeutic use , Administration, Oral , Animals , Artemether , Benzimidazoles/therapeutic use , Bile Ducts/parasitology , Disease Models, Animal , Drug Evaluation, Preclinical , Drug Resistance , Female , Male , Rats , Rats, Sprague-Dawley , Rats, Wistar , Triclabendazole
4.
FASEB J ; 18(1): 114-21, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14718392

ABSTRACT

Many neuropeptide transmitters require the presence of a carboxy-terminal alpha-amide group for biological activity. Amidation requires conversion of a glycine-extended peptide intermediate into a C-terminally amidated product. This post-translational modification depends on the sequential action of two enzymes (peptidylglycine alpha-hydroxylating monooxygenase or PHM, and peptidyl-alpha-hydroxyglycine alpha-amidating lyase or PAL) that in most eukaryotes are expressed as separate domains of a single protein (peptidylglycine alpha-amidating monooxygenase or PAM). We identified a cDNA encoding PHM in the human parasite Schistosoma mansoni. Transient expression of schistosome PHM (smPHM) revealed functional properties that are different from other PHM proteins; smPHM displays a lower pH-optimum and, when expressed in mammalian cells, is heavily N-glycosylated. In adult worms, PHM is found in the trans-Golgi network and secretory vesicles of both central and peripheral nerves. The widespread occurrence of PHM in the nervous system confirms the important role of amidated neuropeptides in these parasitic flatworms. The differences between schistosome and mammalian PHM suggest that it could be a target for new chemotherapeutics.


Subject(s)
Mixed Function Oxygenases/metabolism , Multienzyme Complexes/metabolism , Schistosoma mansoni/enzymology , Amino Acid Sequence , Animals , Cells, Cultured , DNA, Complementary/analysis , Female , Humans , Male , Mice , Mixed Function Oxygenases/genetics , Molecular Sequence Data , Multienzyme Complexes/genetics , Neurons/enzymology , Schistosoma mansoni/anatomy & histology , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL
...